Sign Up Today and Learn More About Kwivik Therapeutics Inc Stock

Invest in or calculate the value of your shares in Kwivik Therapeutics Inc or other pre-IPO companies through EquityZen's platform.

Get Started

Kwivik Therapeutics Inc Stock

Medtech

About Kwivik Therapeutics Inc Stock

Founded

2016

Headquarters

Frisco, TX, US

Notable Investor

Silicon Valley Bank

Total Funding

50.0M

Kwivik Therapeutics Inc. is a pre-IPO medtech company that has developed a way to create medical oxygen from two, dry inert powders. The oxygen is created on demand, without the need for pressurized storage. We combined this "oxygen from powder" technology with innovative biotech, engineering, IoT and AI technologies to develop a robust pipeline of products to disrupt certain respiratory, emergency medical, asthma, cluster headache/migraine, wound care and skin care markets globally, with a combined market size exceeding $750 Billion.

Investors in Kwivik Therapeutics Inc

Discover investors in Kwivik Therapeutics Inc stock and explore their portfolio companies

Kwivik Therapeutics Inc Management

Leadership team at Kwivik Therapeutics Inc

Chief Executive Officer

Julian Ross, MBA

Chief Financial Officer

Jeff Robertson, CPA, CGMA

Locked Features

Join now and verify your accreditation status to gain access to:

  • Kwivik Therapeutics Inc current valuation
  • Kwivik Therapeutics Inc stock price
  • Available deals in Kwivik Therapeutics Inc and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Kwivik Therapeutics Inc stock?

Accredited investors can buy pre-IPO stock in companies like Kwivik Therapeutics Inc through EquityZen funds. These investments are made available by existing Kwivik Therapeutics Inc shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Kwivik Therapeutics Inc stock?

Shareholders can sell their Kwivik Therapeutics Inc stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."